Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
Biomarker discovery can identify molecular markers in various cancers that can be used for detection, screening, diagnosis, and monitoring of disease progression. Lectin-affinity is a technique that can be used for the enrichment of glycoproteins from a complex sample, facilitating the discovery of novel cancer biomarkers associated with a disease state.
Department of Oncology and Diagnostic Sciences, University of Maryland, School of Dentistry, Baltimore, MD 21201, USA.
David
D
Clark
Li
L
Mao
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000097:blood / Q000302:isolation & purification; D055088:Early Detection of Cancer / Q000379:methods; D006023:Glycoproteins / Q000032:analysis* / Q000097:blood / Q000302:isolation & purification; D006031:Glycosylation; D006801:Humans; D037102:Lectins / Q000737:chemistry*; D009369:Neoplasms / Q000097:blood / Q000175:diagnosis; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D006023:Glycoproteins; D037102:Lectins